title: [The ATLAS ACS 2-TIMI 51 study].
authors.affiliation: U O di Cardiologia, Ospedale Maggiore, Bologna. gianni.casella@alice.it
authors.forename: Gianni
authors.initials: G
authors.lastname: Casella
authors.forename: Pier Camillo
authors.initials: PC
authors.lastname: Pavesi
authors.forename: Giulia
authors.initials: G
authors.lastname: Magnani
authors.forename: Diego
authors.initials: D
authors.lastname: Ardissino
mesh_terms: D054058:Acute Coronary Syndrome / Q000150:complications / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D004311:Double-Blind Method; D065427:Factor Xa Inhibitors; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use*
chemical_list: D065427:Factor Xa Inhibitors; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban